Author Archive

Home »

SSR Index of Current-Quarter Healthcare Demand Growth, Interim 2Q13 Estimate

We expect 3.0% (nominal) y/y growth in US health services demand during 2Q13, the product of 1.6% growth in unit demand, and 1.4% price growth. Unit demand growth remains very slow; the projected 1.6% rate is essentially equal tothe inherent

Read More

PBM Bear Thesis Update: The AWP Alternatives Will Soon Be Here

The Center for Medicare and Medicaid Services’ (CMS) final rule replacing average wholesale price (AWP) as a basis for reimbursing pharmacies for generic drugs dispensed to Medicaid beneficiaries will be published this August. The rule will be effective as early

Read More

SSR Index of Current-Quarter Healthcare Demand Growth, Initial 2Q13 Estimate

We expect 2.9% (nominal) y/y growth in US health services demand during 2Q13, the product of 1.5% growth in unit demand, and 1.4% price growth. Unit demand growth remains very slow; the projected 1.4% rate is below the inherent rate

Read More

Buckle Up! A Summary of Adverse Selection Pressures on Health Insurance Exchanges

For most households, the marginal costs of acquiring health coverage on an exchange are within shouting distance of the annual cost of a new car (Exhibit 1); and, the odds of health costs (if uninsured) exceeding costs of coverage (if

Read More

Cheap, Shy, or Just Misbehaving? PFE Sells Viagra Direct to Consumers

PFE announced direct to consumer sales of Viagra; orders placed on Viagra.com will require a legitimate US prescription, and will be filled by CVS Viagra is a perennial favorite of drug counterfeiters. The National Association of Boards of Pharmacy (NABP)

Read More

Why Smaller Employers Will Shift to Self-Funding; Who Wins and Loses

Affordable Care Act (ACA) provisions stand to increase smaller (≤ 100 employee) employers’ premium costs by 20 percent or more in 2014, before accounting for medical trend (+/- 6 pct) The ACA provisions driving the premium increase for smaller employers

Read More

SSR Index of Current-Quarter Healthcare Demand Growth, Final 1Q13 Estimate

We expect 3.7% (nominal) y/y growth in US health services demand during 1Q13, the product of 1.9% growth in unit demand, and 1.8% price growth; unchanged from the 3.7% actual growth rate in 4Q12. Unit demand growth remains very slow;

Read More

SSR Index of Drug and Biotech Pipeline Values

We solve for the share price value of research pipelines by subtracting the NPV of approved and near-to-market products from companies’ enterprise values. We then estimate the relative volume and quality of future products in these pipelines using quality-adjusted patent

Read More

Private Health Exchanges: Why They’re Coming; What They Mean

We believe commercial health insurance markets will shift toward an exchange-based format for employees of all income ranges and employers of all sizes, and that this transition will occur for most employees within three to five years Rather than choosing

Read More

WAG/ABC – Quick Strategic Read-thru; Better for WAG than ABC

Walgreens (WAG) and AmerisourceBergen (ABC) yesterday announced a 10-year agreement in which: ABC handles US brand and generic wholesale distribution operations for WAG; ABC participates in global purchasing using the aggregated buying power of ABC, WAG, and Alliance Boots; and,

Read More
test